2nd European Workshop on
Skin Immune Mediated Inflammatory Diseases (SIMID)
11th - 13th October 2018, Verona, Italy

Program Friday, 12 October 2018

08:30 - 09:00 Lupus erythematosus
S. Beissert (Dresden)
09:00 - 09:30 Dermatomyositis
A. Parodi (Genova)
09:30 - 10:00 Vitiligo
K. Ezzedine (Creteil)
10:00 - 10:30 Alopecia areata
B.M. Piraccini (Bologna)
10:30 - 11:00 Coffee break
11:00 - 11:30 Dimethylfumarate in the treatment of psoriasis
P. Weisenseel (Hamburg)
11:30 - 12:00 Ixekizumab
L. Puig (Barcelona)
12:00 - 12:30 Pustular psoriasis
H. Bachelez (Paris)
12:30 - 13:30 Lunch
13:30 - 13:35 SPONSORED SYMPOSIUM Welcome and introduction
J. Lambert (Gent)
13:35 - 13:50 *SPONSORED* Burden of psoriasis at individual and societal levels
M. Radtke (Hamburg)
13:50 - 14:05 *SPONSORED* Pathophysiology of psoriasis and implications for treatment
J. Lambert (Gent)
14:05 - 14:20 *SPONSORED* Clinical insights into selective IL-23 inhibitors
S. Piaserico (Padua)
14:20 - 14:30 *SPONSORED* Patient case-based discussion and close of meeting
(All)
14:30 - 15:00 Brodalumab, the IL 17 receptor inhibitor: does it make PASI 100 a realistic treatment goal?
M. Augustin (Hamburg)
15:00 - 15:30 Pemphigoids
R. Borroni (Milano)
15:30 - 16:00 Skin manifestations of the autoinflammatory syndromes
A.V. Marzano (Milan)
16:00 - 16:30 Coffee break
16:30 - 17:00 Role of dermatologists in the management of psoriatic arthritis
P. Gisondi (Verona)
17:00 - 17:30 Making patient-centric choices when treating severe psoriasis in women of child bearing age
C. De Simone (Rome)
17:30 - 18:00 Urticaria
M. Metz (Berlin)
18:00 - 18:30 Pemphigus
M. Hertl (Marburg)
18:30 - 19:00 Pharmacogenomics of psoriasis: where we stand
R. Borroni (Milan)